European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 121, Issue 2 , Pages 202-210 , 1 August 2005

Contraceptive efficacy, compliance and beyond: Factors related to satisfaction with once-weekly transdermal compared with oral contraception

  • Wolfgang Urdl

      Affiliations

    • Department for Obstetrics and Gynecology, Unit of Gynecological Endocrinology and Reproductive Medicine, University of Graz, Austria
    • ,
  • Dan Apter

      Affiliations

    • The Sexual Health Clinic, Family Federation of Finland, Helsinki, Finland
    • ,
  • Alan Alperstein

      Affiliations

    • University of Cape Town, Groote Schuur Hospital and Kingsbury Hospital, Cape Town, South Africa
    • ,
  • Peter Koll

      Affiliations

    • Sandton Medi Clinic, Bryanston, South Africa
    • ,
  • Siegfried Schönian

      Affiliations

    • Praxis für Frauenheilkunde, Rheinstetten, Germany
    • ,
  • Jacques Bringer

      Affiliations

    • Hopital Lapeyronie, Montpellier, France
    • ,
  • Alan C. Fisher

      Affiliations

    • Ortho-McNeil Pharmaceuticals, Raritan, USA
    • ,
  • Michael Preik

      Affiliations

    • Medical and Scientific Affairs, Janssen-Cilag GmbH, Neuss, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 2137 955 376; fax: +49 2137 955 642.
    • ,
  • ORTHO EVRA/EVRA 003 Study Group

      Affiliations

    • G. Freude, H. Kittl, A. Staudach, W. Urdl: Austria; J. Amy, M. Degueldre, M. Dhont, A. van Assche: Belgium; U. Ǻgren, D. Apter, E. Granfors, T. Järvi, H. Polvi, P. Sipilä, S. Telimaa, E. Varila: Finland; G. Body, J. Bringer, G. Chaix-Durand, B. Hedon, J.-L. Meyer, C. Quereux, F. Sailly, E. Signon, M. Tournaire: France; K. Greven, R. Klopfer, U. Kohoutek, L. Koos, S. Schönian, R. Schöpp, K. Stahmer, H.-G. Weidenhammer: Germany; A. Borsos, L. Kovacs, Z. Papp, I. Rákóczi: Hungary; S. Friese, F. Helmerhorst, M.V. Kroeks, A. Pennings, L. Pijpers, F. Roumen, J. Schram, H.K. van Weering: Netherlands; A. Malarewicz, S. Radowicki, S. Rozewicki, P. Skalba, M. Szamatowicz, A. Warenik: Poland; A. Alperstein, J. Baker, H. Cronjé, V.A. Hulme, T. Katzeff, P. Koll, J. Moodley, H.C. Odendaal, L. Reynders, G. Tsalacopoulos, Z.M. van der Spuy: South Africa; A. Campana, M. Germond: Switzerland.

Received 30 August 2004 ,Revised 23 December 2004 ,Accepted 28 January 2005.

References 

  1. Population reports. Helping women use the pill. The Johns Hopkins University School of Public Health, vol. 18 [series A, no. 10]; 2000. p. 1–27.
  2. Hatcher RA, Trussell S, Stewart F, et al. Contraceptive technology. Ardent Media; 1998;p. 800–1
  3. Bajos N, Leridon H, Goulard H, Oustry P, Job-Spira N COCON Group. Contraception: from accessibility to efficiency. Hum Reprod. 2003;18(5):994–999
  4. Rosenberg MJ, Waugh MS, Burnhill MS. Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluation. Fam Plan Perspect. 1998;30:89–92104
  5. Fuchs N, Prinz H, Koch U. Attitudes to current oral contraceptive use and future developments: the women's perspective. Eur J Contracept Reprod Health Care. 1996;1:275–284
  6. Abrams LS, Skee DM, Natarajan J, et al. Pharmacokinetics of norelgestromin and ethinyl estradiol delivered by a contraceptive patch (Ortho Evra™/Evra™) under conditions of heat, humidity, and exercise. J Clin Pharmacol. 2001;41:1301–1309
  7. Abrams LS, Skee DM, Natarajan J, Wong FA, Anderson GD. Pharmacokinetics of a contraceptive patch (Evra™/Ortho Evra™) containing norelgestromin and ethinyloestradiol at four application sites. Br J Clin Pharmacol. 2001;53:141–146
  8. Archer DF, Bigrigg A, Smallwood GH, Shangold GA, Creasy GW, Fisher AC. Assesment of compliance with a weekly contraceptive patch (Ortho Evra™/Evra™) among North American women. Fertil Steril. 2002;77(2, Suppl. 2):S27–S31
  9. Archer DF, Cullins V, Creasy GW, Fisher AC. The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy. Contraception. 2002;69:189–195
  10. Audet M-C, Moreau M, Kolton WD, et al. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs. an oral contraceptive. A randomized controlled trial. JAMA. 2001;285:2347–2354
  11. Dardano KL, Burkman RT. Contraceptive compliance. Update Contracept. 2000;27(4):933–941
  12. Egarter C, Topcuoglu MA, Imhof M, Huber J. Low dose oral contraceptives and quality of life. Contraception. 1999;59:287–291
  13. Zacur HA, Hedon B, Mansour D, Shangold GA, Fisher AC, Creasy GW. Integrated summary of Ortho Evra™/Evra™ contraceptive patch adhesion in varied climates and conditions. Fertil Steril. 2002;77(2, Suppl. 2):S32–S35
  14. Note for guidance on clinical investigation of steroid contraceptives in women. Committee for Proprietary Medicinal Products (CPMP); 17-2-2000.
  15. Poindexter AN, Burkman R, Fisher AC, LaGuardia KD. Cycle control, tolerability, and satisfaction among women switching from 30–35microg ethinyl-containing oral contraceptives to the triphasic norgestimate/25microg ethinyl estradio-containing oral contraceptive Ortho Tri-Cyclen LO. Int J Fertil Womens Med. 2003;48(4):163–172
  16. Bishop YM, Fienberg SE, Holland PW. Discrete multivariate analysis: theory and practice. The MIT Press; 1975;
  17. Wysocki S, Schnare SM. Evaluating the efficacy of combined hormonal contraceptives. National Association of nurse practitioners in women's health; 2004;p. 1–9
  18. Zieman M, Guillebau J, Weisberg E, Shangold GA, Fisher AC, Creasy GW. Contraceptive efficacy and cycle control with the Ortho Evra™/Evra™ transdermal system: the analysis of pooled data. Fertil Steril. 2002;77(2, Suppl. 2):S13–S18
  19. Creasy GW, Abrams LS, Fisher AC. Transdermal contraception. Semin Reprod Med. 2001;19(4):373–380
  20. Rosenberg MJ, Waugh MS, Long S. Unintended pregnancies and use, misuse and discontinuation of oral contraceptives. J Reprod Med. 1995;40:355–360
  21. Cramer JA. Compliance with contraceptives and other treatments. Obstet Gynecol. 1996;88:4S–12S
  22. Warner P, Bancroft J. Factors related to self-reporting of the pre-menstrual syndrome. Br J Psychiatry. 1990;157:249–260
  23. Bäckström T, Andreen L, Birzniece V, et al. The role of hormones and hormonal treatments in premenstrual syndrome. CNS Drugs. 2003;17(5):325–342
  24. Freeman EW. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder. Eur J Contracept Reprod Health Care. 2002;7(Suppl. 3):27–34

PII: S0301-2115(05)00054-0

doi: 10.1016/j.ejogrb.2005.01.021

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 121, Issue 2 , Pages 202-210 , 1 August 2005

Article Tools

* Image Usage & Resolution